SABS

SAB Biotherapeutics Inc

3.80

Jun 26 • 04:00PM ET -0.07 (-1.81%)

Healthcare Biotechnology USA Micro NASD

Peers: ELTX ENLV MGNX ABOS CAMP CNTX CRBP KRRO RNA TENX

| Held by: VTI VXF SURI AVSC SBIO

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.47	Insider Own	15.79%	Shs Outstand	75.74M	Perf Week	-5.00%
Market Cap	290.57M	Forward P/E	-	EPS next Y	-0.72	Insider Trans	0.00%	Shs Float	64.39M	Perf Month	5.56%
Enterprise Value	189.35M	PEG	-	EPS next Q	-0.28	Inst Own	76.60%	Short Float	4.47%	Perf Quarter	-0.78%
Income	-26.49M	P/S	-	EPS this Y	-32.73%	Inst Trans	22.58%	Short Ratio	3.67	Perf Half Y	-1.04%
Sales	0.00M	P/B	1.27	EPS next Y	31.78%	ROA	-18.49%	Short Interest	2.88M	Perf YTD	1.60%
Book/sh	3.00	P/C	2.71	EPS next 5Y	3.03%	ROE	-21.31%	52W High	6.60 -42.42%	Perf Year	113.48%
Cash/sh	1.40	P/FCF	-	EPS past 3/5Y	43.07% -	ROIC	-11.39%	52W Low	1.67 127.54%	Perf 3Y	-49.33%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.41% 6.19%	Perf 5Y	-96.18%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	72.96%	Oper. Margin	-	ATR (14)	0.25	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	11.45	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	53.35	Recom	1.08
Dividend Gr. 3/5Y	- -	Current Ratio	11.45	EPS Q/Q	37.01%	SMA20	5.20%	Beta	0.51	Target Price	11.33
Payout	-	Debt/Eq	0.03	Sales Q/Q	-	SMA50	3.03%	Rel Volume	7.17	Prev Close	3.87
Employees	86	LT Debt/Eq	0.02	Earnings	May 12 BMO	SMA200	7.02%	Avg Volume	783.91K	Price	3.80
IPO	Feb 09, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	-64.71% -	Trades		Volume	5,617,154	Change	-1.81%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)